Effects of Berberine on the Gastrointestinal Microbiota

Effects of Berberine on the Gastrointestinal Microbiota

The gastrointestinal microbiota is a multi-faceted system that is unraveling novel contributors to the development and progression of several diseases. Berberine has been used to treat obesity, diabetes mellitus, atherosclerosis, and metabolic diseases in China. There are also clinical trials regard...

Full description

Bibliographic Details
Main Authors:	Lichao Zhang, Xiaoying Wu, Ruibing Yang, Fang Chen, Yao Liao, Zifeng Zhu, Zhongdao Wu, Xi Sun, Lifu Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	berberine intestinal flora obesity diabetes hyperlipidemia
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2020.588517/full

Similar Items

An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae/butyrate/retinoic acid axis
by: Lifu Wang, et al.
Published: (2021-09-01)

Extracellular vesicles derived from Trichinella Spiralis larvae promote the polarization of macrophages to M2b type and inhibit the activation of fibroblasts
by: Ji Wu, et al.
Published: (2022-09-01)

Exosomes Derived From M2b Macrophages Attenuate DSS-Induced Colitis
by: Ruibing Yang, et al.
Published: (2019-10-01)

Knockout of Sema4D alleviates liver fibrosis by suppressing AOX1 expression
by: Lifu Wang, et al.
Published: (2023-09-01)

Exosome-Depleted Excretory-Secretory Products of the Fourth-Stage Larval Angiostrongylus cantonensis Promotes Alternative Activation of Macrophages Through Metabolic Reprogramming by the PI3K-Akt Pathway
by: Shuo Wan, et al.
Published: (2021-07-01)

Extracellular Vesicle-Mediated Communication Within Host-Parasite Interactions
by: Zhenyu Wu, et al.
Published: (2019-01-01)

Case report: A rare case of urinary myiasis induced by the fourth instar larvae of Telmatoscopus albipunctatus.
by: Beibei Zhang, et al.
Published: (2017-12-01)

Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR’s cholesterol-decreasing efficacy in patients
by: Chongming Wu, et al.
Published: (2022-03-01)

Potential Gut Microbiota Features for Non-Invasive Detection of Schistosomiasis
by: Datao Lin, et al.
Published: (2022-07-01)

Corrigendum: Potential gut microbiota features for non-invasive detection of schistosomiasis
by: Datao Lin, et al.
Published: (2022-08-01)

β-Actin: Not a Suitable Internal Control of Hepatic Fibrosis Caused by Schistosoma japonicum
by: Beibei Zhang, et al.
Published: (2019-01-01)

Gut Microbiota Modulates Intestinal Pathological Injury in Schistosoma japonicum-Infected Mice
by: Beibei Zhang, et al.
Published: (2020-11-01)

Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
by: Ya-Fei Liu, et al.
Published: (2023-02-01)

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia
by: Adrian M. Di Bisceglie, et al.
Published: (2020-11-01)

Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia
by: Yuting Chen, et al.
Published: (2022-09-01)

Reversal of liver fibrosis after splenectomy in a patient with advanced schistosomiasis japonica: A case report with 4-year follow-up.
by: Langui Song, et al.
Published: (2019-04-01)

Exosomes Derived from Dendritic Cells Treated with Schistosoma japonicum Soluble Egg Antigen Attenuate DSS-Induced Colitis
by: Lifu Wang, et al.
Published: (2017-09-01)

Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota
by: Chenyang Wu, et al.
Published: (2022-09-01)

Recombinant Sj16 protein with novel activity alleviates hepatic granulomatous inflammation and fibrosis induced by Schistosoma japonicum associated with M2 macrophages in a mouse model
by: Jia Shen, et al.
Published: (2019-09-01)

Schistosome egg-derived extracellular vesicles deliver Sja-miR-71a inhibits host macrophage and neutrophil extracellular traps via targeting Sema4D
by: Yao Liao, et al.
Published: (2023-12-01)

Chi3l3: a potential key orchestrator of eosinophil recruitment in meningitis induced by Angiostrongylus cantonensis
by: Shuo Wan, et al.
Published: (2018-02-01)

Berberine Relieves Metabolic Syndrome in Mice by Inhibiting Liver Inflammation Caused by a High-Fat Diet and Potential Association With Gut Microbiota
by: Jinjin Li, et al.
Published: (2022-01-01)

Berberine alleviates ischemia reperfusion injury induced AKI by regulation of intestinal microbiota and reducing intestinal inflammation
by: Aijing Huo, et al.
Published: (2024-01-01)

Diagnostic Potential of microRNAs in Extracellular Vesicles Derived from Bronchoalveolar Lavage Fluid for Pneumonia—A Preliminary Report
by: Yinfang Sun, et al.
Published: (2022-09-01)

Berberine regulates glucose metabolism in largemouth bass by modulating intestinal microbiota
by: Yun Xia, et al.
Published: (2023-03-01)

Berberine as a Natural Modifier of Gut Microbiota to Promote Metabolic Status in Animal Studies and Clinical Trials: A Systematic Review
by: Mohammad Sadegh Adel-Mehraban, et al.
Published: (2023-04-01)

Genome-Wide Association Study Identifies New Risk Loci for Progression of Schistosomiasis Among the Chinese Population
by: Miao Zhou, et al.
Published: (2022-04-01)

Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats
by: Honglin Sun, et al.
Published: (2016-11-01)

Berberine-Based Carbon Quantum Dots Improve Intestinal Barrier Injury and Alleviate Oxidative Stress in C57BL/6 Mice with 5-Fluorouracil-Induced Intestinal Mucositis by Enhancing Gut-Derived Short-Chain Fatty Acids Contents
by: Liang Wu, et al.
Published: (2023-02-01)

Parasite-Derived Proteins for the Treatment of Allergies and Autoimmune Diseases
by: Zhenyu Wu, et al.
Published: (2017-11-01)

Effects of berberine on intestinal flora of Non-alcoholic fatty liver induced by High-fat diet through 16S rRNA gene segmentation
by: Yuzhen Wang, et al.
Published: (2020-07-01)

Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders
by: Min Liu, et al.
Published: (2023-03-01)

Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism
by: Xiongjie Sun, et al.
Published: (2023-11-01)

The mechanism of berberine alleviating metabolic disorder based on gut microbiome
by: Han Wang, et al.
Published: (2022-08-01)

Berberine Ameliorates Brain Inflammation in Poloxamer 407-Induced Hyperlipidemic Rats
by: Mia Kim, et al.
Published: (2019-11-01)

Semi-quantitative analysis on the content of berberine hydrochloride in compound berberine tablets with the fluorescence spectral imaging method
by: Lan Liang, et al.
Published: (2016-03-01)

Systematic Survey of the Alteration of the Faecal Microbiota in Rats With Gastrointestinal Disorder and Modulation by Multicomponent Drugs
by: Yue Wu, et al.
Published: (2021-11-01)

A Review of the Mechanism of Probiotics Controlling Obesity through Intestinal Flora
by: Yanyan HUANG, et al.
Published: (2023-04-01)

Addition of berberine to formulated feed changes the glucose utilisation, intestinal microbiota and serum metabolites of Largemouth bass (Micropterus salmoides)
by: Yun Xia, et al.
Published: (2022-04-01)

Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota
by: Jiaqiang Deng, et al.
Published: (2022-02-01)